OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹34 Cr | ₹33 Cr | ₹8.07 Cr | ₹17 Cr | ₹16 Cr |
What is the latest Total Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹34 Cr |
Mar2023 | ₹33 Cr |
Mar2022 | ₹8.07 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹16 Cr |
How is Total Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹34 Cr | 2.42 | |
Mar2023 | ₹33 Cr | 307.76 | |
Mar2022 | ₹8.07 Cr | -53.89 | |
Mar2021 | ₹17 Cr | 10.41 | |
Mar2020 | ₹16 Cr | - |
Compare Total Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹217.2 Cr | -10.6% | -15.8% | -16.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,893.0 Cr | 1.5% | 4% | -14.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹171,976.0 Cr | 4.5% | 2.2% | 13.4% | Stock Analytics | |
CIPLA | ₹126,137.0 Cr | -0.2% | -2.5% | -8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,712.0 Cr | 1% | -2.6% | 4.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | -0.2% | -3.7% | -6.6% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -10.6% |
-15.8% |
-16.1% |
SENSEX | 1.6% |
1.7% |
1.8% |
You may also like the below Video Courses